Evaluation of Bcl-2 Family Gene Expression in Hippocampus of 3, 4-methylenedioxymethamphetamine Treated Rats

Sara Soleimani Asl1, Mohammad Hassan Farhadi, Kazem Moosavizadeh

  • 11. Department of Anatomical Sciences, Hamadan University of Medical Sciences, Hamadan, Iran.

Cell Journal
|March 20, 2013
PubMed
Abstract

Insights

3,4-methylenedioxymethamphetamine (MDMA) alters apoptosis by changing Bax and Bcl-2 gene and protein expression in rat hippocampus. This neurotoxic effect is dose-dependent, highlighting MDMA

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Toxicology

Background:

  • 3,4-methylenedioxymethamphetamine (MDMA) is a recreational drug known to induce neurotoxicity.
  • Cellular death, or apoptosis, is a critical process implicated in neurodegenerative conditions.

Purpose of the Study:

  • To investigate the impact of varying MDMA doses on apoptosis-related protein and gene expression.
  • Specifically examining the hippocampus, a brain region crucial for memory and cognition.

Main Methods:

  • Adult male Sprague Dawley rats were administered MDMA (0, 5, 10, 20 mg/kg) twice daily for seven days.
  • Western blot and RT-PCR were employed to quantify Bax and Bcl-2 gene and protein levels.
  • Statistical significance was determined using one-way ANOVA (p≤0.05).

Main Results:

  • MDMA treatment resulted in a dose-dependent increase in Bax expression.
  • Conversely, MDMA led to a dose-dependent decrease in Bcl-2 expression.
  • Significant alterations in the density of bcl-2 and bax genes were observed.

Conclusions:

  • The study suggests that MDMA-induced apoptosis in the hippocampus involves molecular mechanisms related to Bax and Bcl-2.
  • These findings contribute to understanding the neurotoxic potential of MDMA.

Related Concept Videos